Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$624,831
-$450,432 QoQ
Shares Held
10,844
-38.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,408
of 2,506 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $9,612,551 across 15 Drug Manufacturers - General names. BMY ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,869 | $4,640,595 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
7,901 | $998,212 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,216 | $670,256 | |
| 4 | BIIB |
Biogen Inc.
|
2,930 | $633,055 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
10,844 | $624,831 | |
| 6 | AZN |
Astrazeneca PLC
|
2,976 | $564,309 | |
| 7 | AMGN |
Amgen Inc
|
1,185 | $429,112 | |
| 8 | GRFS |
Grifols SA
|
31,637 | $223,989 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $624,831 | 10,844 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,075,263 | 17,729 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $262,633 | 4,869 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $351,063 | 7,584 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,786,153 | 29,286 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,062,479 | 18,785 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $165,568 | 3,200 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $199,344 | 4,800 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $183,839 | 3,390 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $246,288 | 4,800 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $333,033 | 5,738 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $398,792 | 6,236 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $501,873 | 7,241 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $562,720 | 7,821 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $547,179 | 7,697 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $685,069 | 8,897 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $515,445 | 7,058 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $444,306 | 7,126 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $642,645 | 10,861 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $789,946 | 11,822 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $700,490 | 11,096 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,272,793 | 20,519 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,785,307 | 29,612 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $1,831,796 | 31,153 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,610,160 | 28,887 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||